New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
10:03 EDTNLNK, XOMA, BIG, PANW, SWYOptions with decreasing implied volatility: NLNK XOMA BIG PANW SWY
News For NLNK;XOMA;BIG;PANW;SWY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 17, 2014
11:17 EDTNLNKGSK says Ebola vaccine too late for current epidemic, BBC reports
Subscribe for More Information
10:00 EDTBIGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:46 EDTNLNKSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
08:11 EDTBIGBig Lots initiated with a Buy at Stifel
Target $58.
October 16, 2014
07:23 EDTXOMAIBF Conferences to hold a summit
Ophthalmology Innovation Summit is being held in Chicago on October 16.
October 15, 2014
10:49 EDTNLNKEbola linked names rise again amid broader market sell-off
Subscribe for More Information
October 14, 2014
18:20 EDTPANWOn The Fly: After Hours Movers
Subscribe for More Information
17:41 EDTPANWPalo Alto CEO sees reaching operating margins goal within next two years
Subscribe for More Information
17:39 EDTPANWPalo Alto CEO not concerned about margins
17:37 EDTPANWPalo Alto CEO says customers more thoughtful about purchases
Subscribe for More Information
15:01 EDTNLNKNewLink Genetics December volatility elevated at 181 on wide price movement
NewLink Genetics October call option implied volatility of 123, November is at 130, December is at 181; compared to its 26-week average of 104 according to Track Data, suggesting large price movement for this company identified as developing potential Ebola treatments.
11:19 EDTNLNKNIH says several potential Ebola treatments under development
Subscribe for More Information
10:10 EDTNLNKNIH director says supporting BioCryst, Chimerix Ebola treatments
Subscribe for More Information
09:04 EDTNLNKChinese company says drug can cure Ebola, Reuters reports
Subscribe for More Information
October 13, 2014
11:15 EDTNLNKEbola vaccine licensed to NewLink begins human trials
Canada's Minister of Health announced the launch of Phase 1 clinical trials for Canada's Ebola vaccine, which was developed by scientists at the Public Health Agency of Canada's National Microbiology Laboratory. The Canadian government owns the intellectual property associated with this vaccine and has licensed the rights to NewLink Genetics through its wholly owned subsidiary BioProtection Systems. The Phase 1 clinical trial will test the vaccine on a small group of people to assess its safety, determine the appropriate dosage and identify any side effects.
October 12, 2014
19:26 EDTNLNKPatient being evaluated at Boston hospital for possible Ebola, Boston Globe says
Health officials say that a man that recently traveled to Liberia is being assessed at Beth Israel Deaconess hospital in Boston for the Ebola virus, the Boston Globe says. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
19:12 EDTNLNKCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
17:34 EDTPANWJPMorgan to double spending on cybersecurity over next five years, WSJ says
Subscribe for More Information
14:18 EDTNLNKNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTNLNKTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use